Investigator
Linda S Lloyd
STRESS THERAPEUTICS, INC. · funded by NIA, NIAAA
- Companies
- 2
- Grants
- 4
- Non-dilutive funding
- $3.1M
- First award
- Sep 1, 2019
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
Latest Jun 1, 2025.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- STRESS THERAPEUTICS, INC.Momentum in another area
NeuroGrant-only
- STRESS THERAPEUTICS, INC.Momentum in another area
NeuroGrant-only
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- R43
Lead Optimization of a Therapeutic Candidate for Alzheimer’s Disease
$350kJun 1, 2025NIASTRESS THERAPEUTICS, INC.NIH RePORTER · 11077619 (opens the source filing in a new tab)
- U43
Investigational New Drug (IND)-enabling Study for a New Therapeutic for Alcohol Use Disorder (AUD)
$999kMay 15, 2025NIAAASTRESS THERAPEUTICS, INC.NIH RePORTER · 11062330 (opens the source filing in a new tab)
- U43
Investigational New Drug (IND)-enabling Study for a New Therapeutic for Alcohol Use Disorder (AUD)
$995kMay 15, 2025NIAAASTRESS THERAPEUTICS, INC.NIH RePORTER · 11332743 (opens the source filing in a new tab)
- R44
Novel therapeutic for HPA hyperactivity
$717kSep 1, 2019NIAAASTRESS THERAPEUTICS, INC.NIH RePORTER · 11105954 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources